Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 36 No. 4 Signal Transduction Abnormalities...
GENERAL PSYCHOPHARMACOLOGY

Signal Transduction Abnormalities in Schizophrenia: the cAMP System

Psychopharmacology Bulletin 36(4) :92-105 , 2002/10/15

Abstract

Understanding the neurochemistry of schizophrenia involves the study not only of neurotransmitters and their receptors, but also of the signal transduction systems that translate their actions into neural activity. Of particular interest is the signal transduction system involving the second messenger cyclic adenosine monophosphate (cAMP), as all dopamine receptors are either positively or negatively coupled to this system. Studies in blood platelets, cerebrospinal fluid, or postmortem brains of patients with schizophrenia demonstrate abnormalities of stimulated cAMP production. Neuroleptic administration in animal models results in altered cAMP metabolism in a pattern opposite to that seen in schizophrenic patients. These studies suggest that abnormal signal transduction may be involved in the pathogenesis of schizophrenia and that the normalization of this defect may be one mechanism of action of neuroleptic drugs. Psychopharmacology Bulletin. 2002;36(4):92-105

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

E. Chris Muly, MD, PhD. Signal Transduction Abnormalities in Schizophrenia: the cAMP System. Psychopharmacology Bulletin. 2002/10/15; 36(4):92-105.